{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:04:51Z","timestamp":1762459491336,"version":"3.41.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health\u2019s National Institute on Drug Abuse","award":["R43DA033744","R44DA033744"],"award-info":[{"award-number":["R43DA033744","R44DA033744"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbr.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T16:00:57Z","timestamp":1499529657000},"page":"251-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The \u03b13\u03b24 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats"],"prefix":"10.1016","volume":"333","author":[{"given":"Menglu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana M.","family":"Malagon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Belluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurulain T.","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","author":"USDHHS","series-title":"The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General","key":"10.1016\/j.bbr.2017.07.004_bib0005"},{"year":"2015","author":"WHO","series-title":"WHO Report on the Global Tobacco Epidemic, Raising Taxes on Tobacco","key":"10.1016\/j.bbr.2017.07.004_bib0010"},{"key":"10.1016\/j.bbr.2017.07.004_bib0015","series-title":"Trends in Quit Attempts Among Adult Cigarette Smokers\u2014United States, 2001\u20132013, Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention","first-page":"1129","author":"CDC","year":"2015"},{"issue":"1","key":"10.1016\/j.bbr.2017.07.004_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbr.2017.07.004_bib0025","series-title":"Quitting Smoking Among Adults\u2014United States, 2001-2010 Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention","first-page":"1513","author":"CDC","year":"2011"},{"issue":"11","key":"10.1016\/j.bbr.2017.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1742-1241.2008.01885.x","article-title":"Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines","volume":"62","author":"Reus","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2017.07.004_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"issue":"Part A (9)","key":"10.1016\/j.bbr.2017.07.004_bib0040","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.neubiorev.2013.05.002","article-title":"Using conditioned place preference to identify relapse prevention medications","volume":"37","author":"Napier","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"01","key":"10.1016\/j.bbr.2017.07.004_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S1461145713000874","article-title":"Effects of blockade of alpha4beta2 and alpha7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats","volume":"17","author":"Liu","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00213-011-2213-8","article-title":"Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control","volume":"216","author":"Wouda","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-009-1739-5","article-title":"The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats","volume":"208","author":"O'Connor","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"9","key":"10.1016\/j.bbr.2017.07.004_bib0060","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1017\/S1461145711001398","article-title":"Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used","volume":"15","author":"Le Foll","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-007-0967-9","article-title":"Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose","volume":"196","author":"Liu","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le Novere","year":"2002","journal-title":"J. Neurobiol."},{"issue":"7","key":"10.1016\/j.bbr.2017.07.004_bib0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"6663","key":"10.1016\/j.bbr.2017.07.004_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"issue":"5698","key":"10.1016\/j.bbr.2017.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1099420","article-title":"Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization","volume":"306","author":"Tapper","year":"2004","journal-title":"Science"},{"issue":"7047","key":"10.1016\/j.bbr.2017.07.004_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2017.07.004_bib0100","doi-asserted-by":"crossref","first-page":"a012112","DOI":"10.1101\/cshperspect.a012112","article-title":"Molecular mechanisms underlying behaviors related to nicotine addiction","volume":"3","author":"Picciotto","year":"2013","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"5\u20136","key":"10.1016\/j.bbr.2017.07.004_bib0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/FBP.0b013e32830c360e","article-title":"Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice","volume":"19","author":"Fowler","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbr.2017.07.004_bib0110","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/mp.2009.59","article-title":"Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions","volume":"14","author":"Greenbaum","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2017.07.004_bib0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12035-014-8997-x","article-title":"Contribution of variants in CHRNA5\/A3\/B4 gene cluster on chromosome 15 to tobacco smoking: from genetic association to mechanism","volume":"53","author":"Wen","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","article-title":"Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking","volume":"13","author":"Berrettini","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"17","key":"10.1016\/j.bbr.2017.07.004_bib0125","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-09-0786","article-title":"The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans","volume":"69","author":"Saccone","year":"2009","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbr.2017.07.004_bib0130","doi-asserted-by":"crossref","first-page":"e1000125","DOI":"10.1371\/journal.pgen.1000125","article-title":"A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction","volume":"4","author":"Weiss","year":"2008","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0135","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1523\/JNEUROSCI.14-04-02357.1994","article-title":"The developmental increase in ACh current densities on rat sympathetic neurons correlates with changes in nicotinic ACh receptor alpha-subunit gene expression and occurs independent of innervation","volume":"14","author":"Mandelzys","year":"1994","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1523\/JNEUROSCI.17-02-00586.1997","article-title":"Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia","volume":"17","author":"Poth","year":"1997","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2017.07.004_bib0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0028-3908(99)00024-6","article-title":"Alpha3beta4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons","volume":"38","author":"Quick","year":"1999","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1471-4159.2002.00951.x","article-title":"Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography","volume":"82","author":"Perry","year":"2002","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.112.083659","article-title":"Nicotinic receptors in addiction pathways","volume":"83","author":"Leslie","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2017.07.004_bib0160","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/npp.2011.322","article-title":"AT-1001: a high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats","volume":"37","author":"Toll","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.07.004_bib0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2013.09.023","article-title":"[125I]AT-1012, a new high affinity radioligand for the alpha3beta4 nicotinic acetylcholine receptors","volume":"77","author":"Wu","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ntr\/ntu170","article-title":"Functional characterization of AT-1001, an alpha3beta4 nicotinic acetylcholine receptor ligand, at human alpha3beta4 and alpha4beta2 nAChR","volume":"17","author":"Zaveri","year":"2015","journal-title":"Nicotine Tob. Res."},{"issue":"8","key":"10.1016\/j.bbr.2017.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/npp.2014.31","article-title":"Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats","volume":"39","author":"Costello","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2017.07.004_bib0180","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/bph.13034","article-title":"AT-1001: a high-affinity alpha3beta4 nAChR ligand with novel nicotine-suppressive pharmacology","volume":"172","author":"Cippitelli","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-4603(90)90013-N","article-title":"Postcessation cigarette use: the process of relapse","volume":"15","author":"Brandon","year":"1990","journal-title":"Addict. Behav."},{"year":"2010","author":"USDHHS","series-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","key":"10.1016\/j.bbr.2017.07.004_bib0190"},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-7435(85)90035-0","article-title":"Circumstances surrounding relapse in a group of recent exsmokers","volume":"14","author":"Cummings","year":"1985","journal-title":"Prev. Med."},{"issue":"5","key":"10.1016\/j.bbr.2017.07.004_bib0200","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.neubiorev.2012.02.015","article-title":"Tobacco addiction and the dysregulation of brain stress systems","volume":"36","author":"Bruijnzeel","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"0","key":"10.1016\/j.bbr.2017.07.004_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuropharm.2015.02.005","article-title":"Pharmacological stress is required for the anti-alcohol effect of the \u03b13\u03b24* nAChR partial agonist AT-1001","volume":"93","author":"Cippitelli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"45","key":"10.1016\/j.bbr.2017.07.004_bib0210","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1523\/JNEUROSCI.1939-04.2004","article-title":"Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit","volume":"24","author":"Salas","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0215","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.npp.1300586","article-title":"Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats","volume":"30","author":"Belluzzi","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0220","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.npp.1301129","article-title":"Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats","volume":"32","author":"Liu","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2011.09.001","article-title":"Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats","volume":"121","author":"Feltenstein","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(92)90408-8","article-title":"Rodent model of nicotine abstinence syndrome","volume":"43","author":"Malin","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2017.07.004_bib0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02244770","article-title":"The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat","volume":"115","author":"Malin","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3\u20134","key":"10.1016\/j.bbr.2017.07.004_bib0240","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0135-z","article-title":"Bupropion attenuates nicotine abstinence syndrome in the rat","volume":"184","author":"Malin","year":"2006","journal-title":"Psychopharmacology(Berl.)"},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0245","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s002130050200","article-title":"Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms","volume":"129","author":"Hildebrand","year":"1997","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.1994.tb14748.x","article-title":"The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion","volume":"111","author":"Clarke","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0255","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bcp.2015.08.083","article-title":"High affinity \u03b13\u03b24 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice","volume":"97","author":"Khroyan","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2017.07.004_bib0260","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.01.017","article-title":"The alpha3beta4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the alpha5 subunit in the mouse","volume":"70","author":"Jackson","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2017.07.004_bib0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.08.001","article-title":"Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration","volume":"669","author":"Glick","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2017.07.004_bib0270","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00001756-200006260-00041","article-title":"18-MC reduces methamphetamine and nicotine self-administration in rats","volume":"11","author":"Glick","year":"2000","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.bbr.2017.07.004_bib0275","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s002130050716","article-title":"18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats","volume":"139","author":"Glick","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2009.04.019","article-title":"18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference","volume":"458","author":"McCallum","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.bbr.2017.07.004_bib0285","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/jm020562o","article-title":"Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents","volume":"46","author":"Kuehne","year":"2003","journal-title":"J. Med. Chem."},{"issue":"42","key":"10.1016\/j.bbr.2017.07.004_bib0290","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1073\/pnas.1313103110","article-title":"Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons","volume":"110","author":"Gorlich","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbr.2017.07.004_bib0295","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02246272","article-title":"Nicotine self-administration in rats","volume":"122","author":"Donny","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2017.07.004_bib0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-540-69248-5_14","article-title":"Rodent models of nicotine withdrawal syndrome","volume":"192","author":"Malin","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0305","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3565(24)29581-1","article-title":"Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes","volume":"297","author":"Papke","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2017.07.004_bib0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14728214.2014.899580","article-title":"Emerging drugs for the treatment of tobacco dependence: 2014 update","volume":"19","author":"Elrashidi","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bbr.2017.07.004_bib0315","first-page":"Cd009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"year":"1998","author":"Lancaster","series-title":"Mecamylamine (a Nicotine Antagonist) for Smoking Cessation","key":"10.1016\/j.bbr.2017.07.004_bib0320"},{"key":"10.1016\/j.bbr.2017.07.004_bib0325","first-page":"291","article-title":"Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules","volume":"55","author":"Tennant","year":"1984","journal-title":"NIDA Res. Monogr."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817305284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817305284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:17:43Z","timestamp":1750526263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817305284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":65,"alternative-id":["S0166432817305284"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.07.004","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b13\u03b24 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}